Serum Institute of India to invest $68 million in UKs Oxford Biomedica

Written By: Reuters New DelhiReuters Updated on: September 22, 2021, 06.42 PM IST

Oxford Biomedica is one of the COVID-19 vaccine manufacturers for drug major AstraZeneca

Vaccine producer Serum Institute of India will invest $68.24 million in Oxford Biomedica, one of the COVID-19 vaccine manufacturers for drug major AstraZeneca, the British cell therapy firm said on Wednesday.
(More Details Awaited)

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.